HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CEL 2000

a therapeutic vaccine for rheumatoid arthritis; derived from beta2-microglobulin and collagen type II peptide (254-273)

Also Known As:

CEL-2000; CEL2000

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Subunit Vaccines: 1839
      - CEL 2000: 1

Experts

1.	Bendele, Alison: 1 article (04/2010)
2.	Carambula, Roy: 1 article (04/2010)
3.	Duzant, Yvonne: 1 article (04/2010)
4.	Lowe, Valeria: 1 article (04/2010)
5.	O'Neill, Sean P: 1 article (04/2010)
6.	Rosenthal, Kenneth S: 1 article (04/2010)
7.	Talor, Eyal: 1 article (04/2010)
8.	Taylor, Patricia: 1 article (04/2010)
9.	Zimmerman, Daniel H: 1 article (04/2010)

Related Diseases

1.	Disease Progression 04/01/2010 - "CEL-2000 limited disease progression as well or better than the etanercept (Enbrel) therapeutic control with significantly better histopathological results than the etanercept treated mice. "
2.	Rheumatoid Arthritis 04/01/2010 - "CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model."
3.	Arthritis (Polyarthritis) 04/01/2010 - "CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model."

Related Drugs and Biologics

1.	Collagen Type II (Type II Collagen)
2.	Chemokines
3.	Cytokines
4.	Vaccines
5.	Etanercept (Enbrel)